跳至主要内容
临床试验/NCT01586299
NCT01586299Unknown不适用

The Role of Non Steroidal Anti Inflammatory Drugs in the Treatment of Pleuropneumonia in Children. a Randomized Controlled Trial

Rabin Medical Center1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
clinical improvement as manifested by resolution of fever and length of hospital admission.

研究概览

简要总结

The purpose of this study is to evaluate the influence of routine NSAIDs treatment for hospitalized children with pleuropneumonia in comparison with acetominophen treatment (all in conjunction with adequate antibiotic therapy).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • age less than 18 years
  • admission in Schneider childrenMC of Israel, wards a/c
  • clinical diagnosis of pneumonia with evidence of pleural effusion on chest X-ray
  • parental informed consent
  • follow-up ability after discharge

排除标准

  • pneumonia secondary to foreign body aspiration
  • immune deficiency
  • chronic lung disease other than asthma (CF, CLD of prematurity, Familial Dysautonomia, etc)
  • significant premorbidity (organ failure, rheumatic disease, etc)
  • endotracheal/endobronchial devices including tracheostomy.
  • parental refusal to participate in the study.

研究组 & 干预措施

ibuprofen

Experimental

干预措施: Ibuprofen (Drug)

acetaminophen

Active Comparator

干预措施: Acetaminophen (Drug)

结局指标

主要结局

clinical improvement as manifested by resolution of fever and length of hospital admission.

时间窗: participants will be followed for the duration of hospital stay, an expected average of 10 days

次要结局

  • clinical improvement as manifested by respiratory parameters (tachypnea, dyspnea, Fio2),and inflammatory markers.(participants will be followed for the duration of hospital stay, an expected average of 10 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验